SCHEMBL9103721

SCHEMBL9103721

COC(=O)CNCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2361759 0.87 TSHR (0.50)
SCHEMBL26300316 0.86 RECQL (0.43)
SCHEMBL6821739 0.84 RECQL (0.42)
SCHEMBL6817873 0.82 TDP1 (0.43)
Hydrochloric Acid SCHEMBL15855934 0.82 TSHR (0.46)
SCHEMBL1396293 0.81
SCHEMBL73416 0.81 TSHR (0.56)
SCHEMBL8740891 0.81 TSHR (0.40)
SCHEMBL10667342 0.80 TSHR (0.57)
SCHEMBL5680390 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2534138-B1 1,2,3-TRIAZOLE-BASED PEPTIDOMIMETIC INTEGRIN INHIBITORS FOR THE DIAGNOSIS AND THERAPY OF TUMORS UNIVERSITA' DEGLI STUDI DI FIRENZE (IT) 2017-01-25 EP disclosed
US-9301908-B2 Detergent composition P & PF CO., LTD. (JP) 2016-04-05 US disclosed
CN-105294701-A Cyclic P1 linkers as factor XIA inhibitors BRISTOL MYERS SQUIBB CO 2016-02-03 CN disclosed
CN-103702999-B Cyclic P1 linkers as factor XIA inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2015-11-25 CN disclosed
US-9073954-B2 5-substituted benzimidazolium compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-07-07 US disclosed
US-20150112051-A1 CONSTRUCTION OF CELL PENETRATING NUCLEIC ACIDS Panzner, Steffen 2015-04-23 US disclosed
US-20150112051-A1 CONSTRUCTION OF CELL PENETRATING NUCLEIC ACIDS Panzner, Steffen 2015-04-23 US disclosed
US-8957191-B2 Nucleic acid comprising zwitterionic nucleotides STEFFEN PANZNER (DE) 2015-02-17 US disclosed
US-8957191-B2 Nucleic acid comprising zwitterionic nucleotides STEFFEN PANZNER (DE) 2015-02-17 US disclosed
US-8809338-B2 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors UNIVERSITA' DEGLI STUDI DI FIRENZE (IT) 2014-08-19 US disclosed
CN-103702999-A Cyclic p1 linkers as factor xia inhibitors BRISTOL MYERS SQUIBB CO 2014-04-02 CN disclosed
US-20130040964-A1 1,2,3-TRIAZOLE-BASED PEPTIDOMIMETIC INTEGRIN INHIBITORS FOR THE DIAGNOSIS AND THERAPY OF TUMORS UNIVERSITA' DEGLI STUDI DI FIRENZE (IT) 2013-02-14 US disclosed
US-20110137019-A1 NUCLEIC ACID COMPRISING ZWITTERIONIC NUCLEOTIDES BIONTECH PROTEIN THERAPEUTICS GMBH (DE) 2011-06-09 US disclosed
US-20110137019-A1 NUCLEIC ACID COMPRISING ZWITTERIONIC NUCLEOTIDES BIONTECH PROTEIN THERAPEUTICS GMBH (DE) 2011-06-09 US disclosed
US-20100029529-A1 Surfactant having chlorine-capturing ability and anti-discoloration ability and chemical formulation containing the same surfactant KIKUCHI RYUJI 2010-02-04 US disclosed
EP-2143726-A1 Nucleic acid comprising zwitterionic nucleotides Novosom AG (DE) 2010-01-13 EP disclosed
US-20070265181-A1 Surfactant having chlorine-capturing ability and anti-discoloration ability and chemical formulation containing the same surfactant KAWAKEN FINE CHEMICALS CO., LTD. (JP) 2007-11-15 US disclosed
US-20070195309-A1 PHOTOCHROMIC PROBES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2007-08-23 US disclosed
EP-0701432-A1 AQUEOUS SURFACTANT COMPOSITIONS Henkel Kommanditgesellschaft auf Aktien (DE) 1996-03-20 EP disclosed
WO-1994027570-A1 AQUEOUS SURFACTANT COMPOSITIONS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1994-12-08 WO disclosed